MedTrace Logo

TOMO Versus IMRT in Nasopharyngeal Carcinoma Patients

NCT03588403 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2018-07-20

No results posted yet for this study

Summary

Tomotherapy is a new radiation planning and delivery technology which may allow for delivery of higher radiation doses with less damage to normal tissues. The investigators aim to compare the treatment efficacy and quality of life between tomotherapy and intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma

Conditions

  • Nasopharyngeal Carcinoma

Interventions

RADIATION

TOMO

Tomotherapy

RADIATION

IMRT

Intensity modulated radiotherapy

Sponsors & Collaborators

  • Zhejiang Cancer Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2022-07-31
Completion
2022-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03588403 on ClinicalTrials.gov